
Move beyond standard protocols and learn how to dose, manage, and transition GLP therapies for safer, more effective, and sustainable patient outcomes.
Featuring Dr. Ian Ellis, MD
Complimentary for healthcare professionals & practitioners
But the way they are being used is creating a new set of clinical challenges.
"Most protocols were never designed for long-term success. This is where precision medicine changes everything."
In this advanced clinical training, Dr. Ian Ellis, MD, developer of the Mylevel system, will walk you through a more refined, intelligent approach to GLP-1 therapy that prioritizes physiology, sustainability, and patient outcomes.
What You'll Learn
How standard GLP dosing models are contributing to side effects and patient attrition
The pharmacology behind GLP-1s, and why dose matters more than most realize
Precision dosing strategies to improve tolerability and enhance outcomes
How to leverage lower-dose protocols for metabolic, cognitive, and longevity benefits
When and how to titrate, pause, or reduce dosing safely
How to create a clear off-ramp strategy to maintain results post-therapy
Clinical frameworks to integrate GLPs into a broader health optimization model
Featured Speaker

A leader in precision dosing and personalized medicine, and the developer of the Mylevel system.
His work focuses on optimizing pharmacologic interventions through individualized dosing strategies that improve efficacy while minimizing risk, bringing a much-needed evolution to how GLP therapies are used in modern clinical practice.

Who This Is For
This training is designed for clinicians who are actively working with, or preparing to work with, GLP-based therapies and want to:
Improve patient retention and satisfaction
Reduce adverse effects and dosing-related complications
Expand use cases beyond weight loss
Deliver more personalized, physiology-driven care
Elevate their clinical standards in a rapidly evolving landscape
Why This Matters Now
They are becoming a central pillar of modern metabolic care.
With rising patient demand and increasing scrutiny around safety and long-term use, clinicians who rely on outdated dosing strategies risk:
Poor patient outcomes
Increased discontinuation rates
Missed clinical opportunities
"Precision dosing is quickly becoming the new standard, and those who understand it will lead."
Common Questions
No. This training is valuable for both prescribers and non-prescribing practitioners who support patient care, education, and program design.
Yes. Dr. Ellis will cover real-world dosing strategies, titration approaches, and clinical decision frameworks.
No. This training expands into broader metabolic, cognitive, and longevity applications.
Yes. This is a core focus of the training and a major gap in current practice.
Event Details
Date
Thursday, April 16
Time
7:00–8:00 PM EST
Host
Peptide University
Join Dr. Ian Ellis, MD for this advanced clinical masterclass and learn how to deliver safer, smarter, and more effective GLP-1 protocols.
Reserve your seat now
Stay ahead of the standard of care
Elevate your clinical outcomes immediately
We use cookies to enhance your experience.
We use cookies and similar technologies to deliver our educational platform, analyze site traffic, and improve relevance. By continuing, you accept our use of cookies. Read the Cookie Policy.